• Center on Health Equity & Access
  • Clinical
  • Health Care Cost
  • Health Care Delivery
  • Insurance
  • Policy
  • Technology
  • Value-Based Care

Robert Gamble Discusses Patient-Centered Medical Homes Option for Cancer Patients

Article

Mr. Robert “Bo” Gamble, Director, Strategic Practice Initiatives, Community Oncology Alliance in Washington, DC, addresses how the ACO model isn’t a good fit for cancer care because of unpredictability and the high cost of oncology medications.

Mr. Gamble also discusses the standards set by the NCQA and why he thinks they are on target with coordination, outreach, and patient satisfaction, but that the value component is missing for cancer care.

Related Videos
Ivo Carre, PhD, senior business analyst, Lifescience Dynamics
Antonio Urbina, MD
Drs Yelena Janjigian and Zev Wainberg | Background image credit: ipopba - stock.adobe.com
Tina Bhatnagar, DO
Peter Voorhees, MD, Atrium Health Levine Cancer Institute
Antonio Urbina, MD
Ciara Zachary, PhD, MPH
Hearn Jay Cho, MD, PhD
Nicoletta Colombo, MD, PhD
Related Content
Patients and dermatologists found polarized dermatoscopes easier to use and producing higher-quality images, but their higher cost may limit broader adoption in teledermoscopy. | Image credit: wavebreak3 - stock.adobe.com.jpg

Polarized Dermatoscopes Improve Teledermoscopy Image Quality but Raise Cost Barriers

December 4th 2025
Article

Polarized dermatoscopes produced higher-quality teledermatology images but at greater cost, raising questions about feasibility and equitable access.

Read More

Managed Care Cast

Frameworks for Advancing Health Equity: Dental Health Care Access

December 2nd 2025
Podcast

Explore innovative strategies in dental care that are enhancing access, promoting health equity, and improving community health in Pennsylvania.

Listen

New insights on the effectiveness of guideline-recommended HF therapies in Chagas disease. | Image credit: appledesign - stock.adobe.com

Heart Failure Therapies Show Limited Impact in Chagas Disease

December 3rd 2025
Article

Guideline-recommended HF therapies do not improve major outcomes in Chagas disease, though sacubitril/valsartan improved NT-proBNP levels, new data show.

Read More

Managed Care Cast Square thumbnail

Managed Care Cast Presents: New Evidence and Economic Considerations in IPF Care

November 25th 2025
Podcast

Experts discuss the clinical and economic burden of idiopathic pulmonary fibrosis (IPF), emerging clinical data, and strategies to improve patient outcomes.

Listen

How expiring ACA subsidies could reshape coverage choices for employees and employers. | Image credit: @iQoncept-stock.adobe.com.jpeg

What ACA Subsidy Expiration Means for Coverage Costs, Employer Strategy, and ICHRAs: Q&A With Ben Light

December 2nd 2025
Article

With ACA subsidies ending in 2025, Ben Light explains how rising premiums may push individuals toward ICHRAs and reshape employer health coverage strategy.

Read More

New research shows patients in fee-for-service settings face higher odds of low-value surgical care, underscoring the potential benefits of salaried payment models. | Image credit: @Ekahardiwito-AdobeStock.jpeg

Fee-for-Service Models Linked to Higher Odds of Low-Value Surgical Procedures

December 2nd 2025
Article

A new study shows fee-for-service care is linked to higher odds of low-value surgery, suggesting salaried models may reduce unnecessary procedures.

Read More

© 2025 MJH Life Sciences
AJMC®
All rights reserved.